会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Canine IL-13 nucleic acid molecules and fragments thereof
    • 犬IL-13核酸分子及其片段
    • US07026139B2
    • 2006-04-11
    • US10262439
    • 2002-09-30
    • Shumin Yang
    • Shumin Yang
    • C12P21/06C12N5/00C12N15/00C12N15/63C07H21/02
    • C07K14/475A61K38/00A61K48/00A61K2039/51C07K14/52C07K14/535C07K14/54C07K14/5406C07K14/5409C07K14/5437C07K14/56C07K14/70575C07K14/70578C07K16/247C12N2799/021
    • The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    • 本发明涉及犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白细胞介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 对犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF核酸分子,包括 分别编码犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 针对这种蛋白质产生的抗体; 以及调节这些蛋白质的抑制性化合物。 本发明还包括鉴定和获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这些蛋白质,核酸分子,抗体和/或抑制化合物的治疗组合物,以及这些治疗组合物在动物体内调节免疫应答的用途。
    • 4. 发明授权
    • Canineil-4nucleic acid molecules and uses thereof
    • Canineil-4核酸分子及其用途
    • US07078506B2
    • 2006-07-18
    • US10218654
    • 2002-08-13
    • Gek-Kee SimShumin YangMatthew J. DreitzRamani S. Wonderling
    • Gek-Kee SimShumin YangMatthew J. DreitzRamani S. Wonderling
    • C07H21/02C07H21/04C12P21/06C12N5/00C12N15/00C12N15/63C07K1/00
    • C07K14/475A61K38/00A61K2039/51C07K14/535C07K14/54C07K14/5406C07K14/5409C07K14/5437C07K14/56C07K14/70575C07K14/70578C07K16/247C12N2799/021
    • The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    • 本发明涉及犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白细胞介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 对犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF核酸分子,包括 分别编码犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 针对这种蛋白质产生的抗体; 以及调节这些蛋白质的抑制性化合物。 本发明还包括鉴定和获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这些蛋白质,核酸分子,抗体和/或抑制化合物的治疗组合物,以及这些治疗组合物在动物体内调节免疫应答的用途。
    • 8. 再颁专利
    • Canine IL-13 immunoregulatory proteins and uses thereof
    • 犬IL-13免疫调节蛋白及其用途
    • USRE40374E1
    • 2008-06-10
    • US10918292
    • 2004-08-13
    • Shumin Yang
    • Shumin Yang
    • A61K45/00C07K1/00C07H21/04C12P21/06
    • C07K14/475A61K38/00A61K48/00A61K2039/51C07K14/535C07K14/54C07K14/5406C07K14/5409C07K14/5437C07K14/56C07K14/70575C07K14/70578C07K16/247C12N2799/021
    • The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    • 本发明涉及犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白细胞介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 对犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF核酸分子,包括 分别编码犬白细胞介素-4,犬或猫Flt-3配体,犬或猫CD40,犬或猫科动物CD154,犬白介素-5,犬白细胞介素-13,猫干扰素α和/或猫GM-CSF蛋白 ; 针对这种蛋白质产生的抗体; 以及调节这些蛋白质的抑制性化合物。 本发明还包括鉴定和获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这些蛋白质,核酸分子,抗体和/或抑制化合物的治疗组合物,以及这些治疗组合物在动物体内调节免疫应答的用途。